News Update Phase II, III trials of Covaxin on volunteers aged 2-18 years, challenged : Delhi HC 19 May 2021 The Phase II & III clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI), for in the age group of 2…
News Update Centre increases gap between two doses of Covishield to 12-16 weeks 13 May 2021 The gap between the first and second doses of the Covishield COVID-19 vaccine has been increased to 12-16 weeks - from the existing six-eight weeks - the government said. The…
News Update Rs 250 for one dose of Covid vaccine 28 Feb 2021 Government said that private hospitals can charge upto Rs.250 maximum for one dose of corona vaccine. While the vaccine is being given free of cost at the government centres, people…
News Update Covaxin’s 20,000 doses arrive Bengaluru, to be used side by side with Covishield 14 Jan 202114 Jan 2021 Since January 12, Bengaluru had already received 8 lakh doses of Covishield from Pune based Serum Institute of India .The main cluster of Covaxin from Hyderabad-based Bharat Biotech of 20,000…
News Update DCGI Approves Serum Institute’s ‘Covishield’ , Bharat Biotech ‘Covaxin’ Vaccines for Emergency Restricted Use 3 Jan 2021 India's drug controller Drugs Controller General of India(DCGI) has approved Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' for restricted emergency use. This was informed by Dr VG Somani,…
News Update Covid-19 vaccine: Dry run in Punjab, Assam, Andhra Pradesh and Gujarat 27 Dec 2020 The exercise of dry run vaccine will continue for two days, December 28 and 29, in two districts each. There will be no vaccine involved in the process, which will…
News Update Covaxin activates immune responses, no side effects: Bharat Biotech 24 Dec 2020 As per the information available in the research paper published by a Hyderabad based firm, the Bharat Biotech Covid vaccine is in the late stage clinical trials and haven't shown…
News Update Bharat Biotech to launch Covaxin by 2021 after approval 1 Nov 2020 Pharmaceutical Company Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities. The…
News Update Phase-1 of clinical trial for Covaxin begins at AIIMS 25 Jul 2020 On Friday, a 30 year old man was administered the first dose of India's indigenous COVID vaccine. He became the first person to test the Bharat Biotech's Covaxin at AIIMS,…
